최신 NBMTM Certification BCMTMS 무료샘플문제:
1. A well-Known patient at the MTM clinic has been recently diagnosed with Parkinson's disease, andthe patient's current medication listnow includes:
* carbidopa/;levodopa 25mg/100mg t.i.d
* ropinirole 0.25mg LLd.
- rerrous suirate 325mg daily
* lisinopril 10mg daily
Based on this medication list, which counseling point would be most appropriate for me patient?
A) Ferrous sulfate should he separated from carbidopa/levodopa doses by at least 2 hours
B) Blood pressure should be monitored closely due to risk of hypertension with ropinirole.
C) Loperamide should be used to treat diarrhea caused by carbidopa/levodopa
D) A diet highin proteinwin enhance the effectiveness of carbidopa/levodopa
2. A 45-year-old male patient who has diabetic peripheral neuropathy is picking up a prescription for pregabalin.
During pick up. the patient reveals working a jobthat requires constant walking the patientexperiences suboptimal reliet of diabetic neuropathy and inquires about over the counter (OTC) pain relief options Which response by thepharmacist would be MOST appropriate?
A) Use a topical lidocaine
B) Use a capsaicin cream.
C) Use a triple antibiotic ointment
D) Do not use OTC treatments when taking pregabalin.
3. A 79-year-old patient presents to the pharmacy and complains of dry cough which started last week. The patient has a current medication list that includes: levothyroxine, metoprolol, sertraline, and lisinopril. The patient should be notified that the cough may be a side effect of taking which medication?
A) Sertraline
B) Lisinopril
C) Levothyroxine
D) Metoprolol
4. Which statement BEST describes the relationship between the Group Health Research institute chronic care model (CCM) and medication therapy management (MTM)
A) CCM is a specialized style of MTM used specifically for long-term care facility residents.
B) CCM is a specialized, multifaceted method for Dining for MTM services.
C) CCM is a multidimensional, systems based approach for chronic care which can include MTM
D) CCM is a documentation strategy in chronic care patients who qualify for MTM services.
5. A patientis newly diagnosed with ADHD andmuscular dystropny. The patient's physician wants to ado atomoxetine to the patent's treatment regimen Testing mat reveals inepatient is a poor metaholizer ofwhich enzyme would indicate that the medication Should beAVOIDED'?
A) CYP2DG
B) CYP3A4
C) CYP2B6
D) CYP450
질문과 대답:
질문 # 1 정답: B | 질문 # 2 정답: B | 질문 # 3 정답: B | 질문 # 4 정답: C | 질문 # 5 정답: D |